Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis

NCT ID: NCT06571981

Last Updated: 2025-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of abdominal US exam in patients with viral hepatitis between ultraportable US with teleradiology capacities (TUP) versus conventional ultrasound (CUS)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective The investigation seeks primarily to determine the performance of abdominal US examinations realized with TUP and CUS based on defined imaging criteria Secondary Objectives Evaluate satisfaction and comfort and reproducibility of use of the ultraportable US

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis Teleradiology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with viral hepatitis

Every outpatient referred to the radiology department by a prescriber for abdominal US in the context of viral hepatitis

TUP ultraportable US with teleradiology capacities

Intervention Type DEVICE

Comparison of abdominal ultrasound examinations in an at-risk population diagnosed with viral hepatitis: Ultraportable ultrasound with teleradiology capacities (TUP) versus conventional ultrasound (CUS).

CUS conventional ultrasound

Intervention Type DEVICE

Comparison of abdominal ultrasound examinations in an at-risk population diagnosed with viral hepatitis: Ultraportable ultrasound with teleradiology capacities (TUP) versus conventional ultrasound (CUS).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TUP ultraportable US with teleradiology capacities

Comparison of abdominal ultrasound examinations in an at-risk population diagnosed with viral hepatitis: Ultraportable ultrasound with teleradiology capacities (TUP) versus conventional ultrasound (CUS).

Intervention Type DEVICE

CUS conventional ultrasound

Comparison of abdominal ultrasound examinations in an at-risk population diagnosed with viral hepatitis: Ultraportable ultrasound with teleradiology capacities (TUP) versus conventional ultrasound (CUS).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed Consent signed by the subject
* All adult patients with viral hepatitis for which an ultrasound is planned

Exclusion Criteria

* Known or suspected non-compliance
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
* Previous enrollment into the current study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Naik Vietti Violi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Naik Vietti Violi

PD & MERc, Executive Physician of Diagnostic And Interventional Radiology Department

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Naïk Vietti Violi, MD

Role: STUDY_DIRECTOR

CHUV-UNIL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lausanne University Hospital

Lausanne, Canton of Vaud, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Naïk Vietti Violi, MD

Role: CONTACT

+41795560240

Giuseppe Gullo, MSc

Role: CONTACT

+41213144444

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Naïk Vietti Violi, MD

Role: primary

+417955600240

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BASEC 2024-D0048

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.